2020 IDSA临床和诊断建议:急性呼吸道感染的分子检测

2020-05-05 美国感染病学会 Clin Infect Dis. 2020 May 5.

2020年5月,美国感染病学会(IDSA)诊断委员会发布了急性呼吸道感染的分子检测诊断建议。急性呼吸道感染的症状和体征不具有病原体特异性,高灵敏度、特异性的核酸扩增试验已经成为病毒诊断的参考标准。本文

中文标题:

2020 IDSA临床和诊断建议:急性呼吸道感染的分子检测

英文标题:

Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA's Diagnostics Committee.

发布机构:

美国感染病学会

发布日期:

2020-05-05

简要介绍:

2020年5月,美国感染病学会(IDSA)诊断委员会发布了急性呼吸道感染的分子检测诊断建议。急性呼吸道感染的症状和体征不具有病原体特异性,高灵敏度、特异性的核酸扩增试验已经成为病毒诊断的参考标准。本文主要总结了当前急性呼吸道感染病毒和细菌诊断的最新进展并提供诊断决策框架和指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 IDSA临床和诊断建议:急性呼吸道感染的分子检测.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bab6d1c00190a4cf, title=2020 IDSA临床和诊断建议:急性呼吸道感染的分子检测, enTitle=Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA's Diagnostics Committee., guiderFrom=Clin Infect Dis. 2020 May 5., authorId=0, author=, summary=2020年5月,美国感染病学会(IDSA)诊断委员会发布了急性呼吸道感染的分子检测诊断建议。急性呼吸道感染的症状和体征不具有病原体特异性,高灵敏度、特异性的核酸扩增试验已经成为病毒诊断的参考标准。本文, cover=https://img.medsci.cn/2020513/1589380519713_2020535.jpg, journalId=0, articlesId=null, associationId=61, associationName=美国感染病学会, associationIntro=美国感染病学会(IDSA)是面向专门从事传染病的医生、科学家和其他医护人员的学会。 核心宗旨是:为临床增加可靠性证据,促进分享以减少传染病给社会带来的经济负担,促进学会成员与其他专业同事之间的合作与交流。, copyright=0, guiderPublishedTime=Tue May 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年5月,美国感染病学会(IDSA)诊断委员会发布了急性呼吸道感染的分子检测诊断建议。急性呼吸道感染的症状和体征不具有病原体特异性,高灵敏度、特异性的核酸扩增试验已经成为病毒诊断的参考标准。本文主要总结了当前急性呼吸道感染病毒和细菌诊断的最新进展并提供诊断决策框架和指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=22166, tagName=急性呼吸道感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=22166, guiderKeyword=急性呼吸道感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2762, appHits=106, showAppHits=77, pcHits=936, showPcHits=2705, likes=0, shares=4, comments=3, approvalStatus=1, publishedTime=Wed May 13 23:15:05 CST 2020, publishedTimeString=2020-05-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed May 13 22:35:23 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:02:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 IDSA临床和诊断建议:急性呼吸道感染的分子检测.pdf)])
2020 IDSA临床和诊断建议:急性呼吸道感染的分子检测.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1212151, encodeId=49d01212151d5, content=收藏学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 18 12:03:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011393, encodeId=64c71011393cf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75065584716, createdName=ms4000000339492774, createdTime=Wed Aug 25 15:42:25 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011392, encodeId=df78101139267, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75065584716, createdName=ms4000000339492774, createdTime=Wed Aug 25 15:42:03 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2022-04-18 ms3000000771933475

    收藏学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212151, encodeId=49d01212151d5, content=收藏学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 18 12:03:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011393, encodeId=64c71011393cf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75065584716, createdName=ms4000000339492774, createdTime=Wed Aug 25 15:42:25 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011392, encodeId=df78101139267, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75065584716, createdName=ms4000000339492774, createdTime=Wed Aug 25 15:42:03 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-25 ms4000000339492774

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1212151, encodeId=49d01212151d5, content=收藏学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 18 12:03:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011393, encodeId=64c71011393cf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75065584716, createdName=ms4000000339492774, createdTime=Wed Aug 25 15:42:25 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011392, encodeId=df78101139267, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75065584716, createdName=ms4000000339492774, createdTime=Wed Aug 25 15:42:03 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-08-25 ms4000000339492774

    好资料

    0

拓展阅读

2023 NICE 卫生技术评价:急性呼吸道感染的虚拟病房平台技术【HTE13】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-10-12

2023 NICE 质量标准:16岁以上的急性呼吸道感染的初步评估和管理,包括虚拟病房(在家医院)【QS210】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-10-31